sever
acut
respiratori
syndrom
sar
recent
discov
viral
diseas
character
fever
cough
acut
fibrin
pneumonia
high
infect
specif
pathogenfre
spf
chicken
immun
inactiv
sar
coronaviru
egg
harvest
regular
interv
yolk
immunoglobulin
igi
extract
use
water
dilut
method
follow
purif
sephadex
column
sdspolyacrylamid
gel
electrophoresi
sdspage
western
blot
neutral
test
result
show
igi
obtain
high
puriti
strong
reactiv
activ
neutral
titer
lyophil
stabil
test
show
lyophil
antisar
coronaviru
igi
promis
physic
properti
signific
reduct
reactiv
activ
good
thermal
stabil
data
suggest
antisar
coronaviru
igi
could
new
use
biolog
product
specif
antivir
therapi
sar
sever
acut
respiratori
syndrom
sar
recent
discov
viral
diseas
character
fever
cough
acut
fibrin
pneumonia
high
infect
chang
outbreak
sar
caus
concern
around
world
seriou
health
threat
comprehens
prevent
treatment
measur
taken
intern
time
research
sar
coronaviru
develop
vaccin
therapeut
drug
biolog
product
commenc
immedi
research
success
consider
progress
made
field
chow
et
al
analys
nucleotid
amino
acid
sequenc
sar
coronaviru
demonstr
belong
three
known
subgroup
coronavirus
therefor
identifi
new
kind
coronaviru
wang
ding
recent
progress
made
product
biolog
product
sar
hightit
human
antiserum
sar
coronaviru
found
capabl
correspond
author
tel
fax
email
address
xgkong
hvriaccn
xg
kong
inhibit
multipl
sar
viru
prospect
confirm
passiv
immun
sar
infect
patient
noninfect
individu
risk
feasibl
passiv
immun
shortterm
protect
high
antibodi
titer
histor
effect
way
combat
fulmin
infecti
diseas
outbreak
sar
china
posit
result
achiev
passiv
immun
sera
recov
sar
patient
use
advers
reaction
observ
first
vaccin
volunt
order
provid
new
effect
passiv
immun
sar
basic
studi
sar
coronaviru
antibodi
carri
studi
includ
search
better
antibodi
sourc
increas
output
improv
techniqu
product
purif
studi
success
immun
specif
pathogenfre
spf
chicken
purifi
hightit
antisar
coronaviru
yolk
immunoglobulin
igi
neutral
activ
sar
coronaviru
sar
coronaviru
antigen
prepar
use
sar
viru
strain
kindli
provid
chines
academi
militari
inactiv
purifi
sucros
gradient
centrifug
describ
previous
yin
liu
thirti
spf
leghorn
hen
provid
experiment
anim
center
harbin
veterinari
research
institut
chines
academi
agricultur
scienc
harbin
china
chicken
immun
inject
mg
sar
coronaviru
antigen
pector
muscl
second
third
booster
inject
mg
antigen
administ
week
later
blood
harvest
immun
egg
harvest
becam
avail
isol
igi
individu
egg
perform
use
protocol
describ
akita
nakai
briefli
egg
white
separ
egg
yolk
discard
yolk
mix
vigor
steril
water
left
stand
overnight
c
mixtur
centrifug
g
c
min
supernat
purifi
chromatographi
protein
concentr
harvest
eluat
measur
thinlay
gel
scan
recoveri
rate
crude
protein
chromatographi
found
puriti
chromatographi
eluat
subject
analysi
sdspolyacrylamid
gel
electrophoresi
sdspage
western
blot
isol
igi
high
puriti
confirm
sdspage
purifi
igi
good
biolog
activ
confirm
western
blot
activ
igi
sera
yolk
dilut
phosphat
buffer
salin
pb
immun
anim
assess
use
indirect
elisa
assay
describ
previous
huang
et
al
fig
immun
spf
chicken
sar
coronaviru
antigen
detect
antibodi
sar
coronaviru
yolk
egg
laid
first
week
first
immun
product
antisarsv
antibodi
yolk
found
commenc
week
igi
produc
serum
igyneutr
viru
assay
perform
laminarflow
safeti
cabinet
briefli
serial
dilut
sampl
igi
incub
tcid
sar
coronaviru
c
h
inocul
onto
vero
cell
incub
c
co
incub
uninfect
vero
cell
sarsposit
serum
spf
chicken
serum
use
control
experi
igi
react
vero
cell
test
indirect
fluoresc
antibodi
techniqu
infect
titer
calcul
use
standard
tcid
assay
highest
antibodi
dilut
inhibit
cytopath
effect
vero
cell
inocul
dilut
regard
neutral
titer
result
neutral
experi
tabl
indic
yolk
antibodi
till
dilut
effect
neutral
sar
coronaviru
consist
elisa
result
extract
yolk
antibodi
use
lyophil
procedur
yolk
isol
mix
phosphat
buffer
salin
ratio
vv
follow
centrifug
degreas
aliquot
load
bottl
less
gml
merthiol
ad
bottl
vacuum
lyophil
accord
standard
method
sampl
test
antibodi
titer
lyophil
igi
dri
show
good
physic
properti
includ
pale
yellow
color
bind
activ
igi
elisa
chang
significantli
lyophil
tabl
stabil
test
lyophil
igi
demonstr
igi
bind
decreas
significantli
temperatur
reach
c
min
hot
water
tabl
indic
igi
good
heat
stabil
chang
igi
activ
acid
condit
ph
treatment
c
h
tabl
furthermor
bind
activ
lyophil
igi
chang
storag
either
c
room
temperatur
tabl
igi
spf
chicken
provid
rich
sourc
antibodi
easi
obtain
cost
effect
advantag
spf
chicken
igi
antibodi
mammal
includ
high
concentr
freedom
specif
pathogen
make
use
igi
broader
prospect
develop
schade
et
al
tini
et
al
igi
spf
chicken
studi
maintain
good
biolog
neutral
activ
environment
condit
recoveri
rate
purif
water
dilut
level
puriti
purif
promis
bind
igi
remain
unchang
lyophil
also
make
feasibl
product
prepar
way
use
passiv
immun
shortterm
protect
sinc
first
outbreak
sar
transmiss
viru
control
potenti
epidem
allevi
isol
suspect
patient
combin
drug
therapi
base
clinic
epidemiolog
characterist
sar
longterm
control
sar
howev
requir
combin
activ
passiv
immun
drug
therapi
comprehens
measur
therefor
vital
import
abl
produc
vaccin
passiv
immun
product
effect
control
sar
develop
hightit
antisar
coronaviru
igi
describ
studi
would
appear
potenti
new
antisar
biolog
product
passiv
immun
effect
neutral
sar
coronaviru
present
studi
antisar
igi
alreadi
prepar
crude
purifi
product
indirect
elisa
test
use
qualiti
control
igi
product
facilit
process
mass
product
purifi
igi
techniqu
degreas
purif
would
key
point
studi
evalu
use
experiment
infect
anim
model
antisar
igi
produc
studi
potenti
commerci
manufactur
effic
capsul
produc
crude
igi
spray
powder
intraven
solut
manufactur
highli
refin
igi
need
determin
next
step
develop
igi
product
